Healthcare & Life Sciences
Glycomine
United Stateswww.glycomine.com
Glycomine is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 3 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2020
Founded
3
Investors
About Glycomine
Glycomine is a startup founded in 2020 based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Glycomine is a biotechnology company focused on developing replacement therapies for rare genetic diseases, specifically targeting phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG) with its lead candidate GLM101, a mannose-1-phosphate replacement therapy.
Explore Glycomine's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.